Ru

Investors

Financial results Ratings
Operating profit in 2024
6.2
bln RUB
OIBDA in 2024
9.6
bln RUB
Revenue in 2024
36.7
bln RUB

Financial results

Detailed information
Consolidated financial statements for 2023 and independent auditor's report
More details
Consolidated financial statements for 2022 and independent auditor's report
More details
Unaudited condensed interim consolidated financial statements for 6M ended 30 June 2021
More details
Combined and consolidated financial statements for 2020 and an independent auditor's report
More details

Ratings

Binnopharm Group’s credit ratings are assigned by rating agencies based on the assessment of the Company's strategy, development plans, current leverage and financial stability


Expert RA
ruA
Outlook stable
09/06/2024
In accordance with the Russian law, Binnopharm Group publishes information subject to disclosure by Issuers of Issue-Grade Securities on the website
https://www.e-disclosure.ru/portal/company.aspx?id=38507 of the security market information provider Interfax-CIDC certified by the Bank of Russia for disclosure purposes. Any information published on this website is for informational purposes only and may not be considered a public offer as defined in Clause 437 of the Russian Civil Code.
Security hotline
Our Security Hotline helps ensure the efficiency of the Company’s measures to combat potential abuse, fraud, corruption, errors and omissions.
You can use the Hotline to report non-performance or improper performance by Binnopharm Group employees of their duties, as well as non-compliance or improper compliance with charters, internal documents, legal requirements, etc. at a time and in a form convenient, including anonymously, by:
emailing to report@binnopharmgroup.ru;
calling +7 800 600 08 24 or +7 495 510 32 88 ext. 3333 and leaving a voice message;
sending a letter marked “personal – SECURITY HOTLINE” Attn.: Internal Audit Director, to the following address: 14 Kozhevnicheskaya St., Bld. 5, 3rd Floor, Moscow, 115114 (Binnopharm Group);
using the feedback form:
File size must not exceed 8 Mb.
    Your reports will be confidentially registered by authorised Binnopharm Group employees for further review and verification. If you are or plan to become a counterparty of Binnopharm Group facilities, and believe that they violate procurement procedures, you can officially contact the Commission for Procurement Disputes at Sistema.
    Подтверждение номера телефона
    Введите код из СМС